Search
Avalo Therapeutics Inc
AVTXAdd to Watchlist
18.840USD
+1.550+8.96%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
335.87MMarket Cap
LossP/E TTM
Avalo Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Avalo Therapeutics Inc is 6.91, ranking 282 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -3.39, which is -141.76% below the recent high of 1.41 and -15.69% above the recent low of -3.92.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.